北美原住民易感血清阳性类风湿关节炎的分子基础
研究比较344例北美原住民RA患者与352例对照的HLA基因型,并通过晶体结构及T细胞分析,发现HLA-DRB1*14:02因His13βSer多态性改变P4口袋,能同时呈递瓜氨酸化和精氨酸化波形蛋白59-71,扩增自身反应性CD4+ T细胞,从而增加ACPA阳性RA风险。
要点
- HLA-DRB1*14:02与北美原住民ACPA阳性RA独立相关。
- 该等位基因His13βSer多态性使P4口袋可容纳瓜氨酸和精氨酸。
- 患者及高危亲属中可检测到针对两种肽段的寡克隆自身反应性CD4+ T细胞。
核心结论
- HLA-DRB1*14:02通过拓宽瓜氨酸化及天然自身肽的呈递能力并扩增T细胞,增加ACPA阳性RA风险。
研究设计与样本
- 比较344例北美原住民RA患者与352例对照的HLA基因型,并用X射线晶体学解析HLA-DRB1*1402-Ⅱ类分子与三种肽段的结构,用四聚体流式细胞术及TCR测序分析抗原特异性CD4+ T细胞。
主要发现
- 北美原住民中ACPA阳性RA与HLA-DRB1*14:02独立相关。
- HLA-DRB1*14:02因His13βSer多态性和P4口袋改变,能以相反方向容纳瓜氨酸和精氨酸。
- 在HLA-DRB1*14:02阳性RA患者及ACPA阴性一级亲属中观察到针对波形蛋白59-71瓜氨酸和精氨酸两种形式的寡克隆自身反应性CD4+效应T细胞。
- HLA-DRB1*14:02-波形蛋白59-71特异性和HLA-DRB1*14:02-波形蛋白-64Cit59-71特异性CD4+记忆T细胞是表型不同的群体。
临床怎么用
- 对北美原住民ACPA阳性RA高危个体,可考虑HLA-DRB1*14:02检测以辅助风险评估。
- HLA-DRB1*14:02阳性者中针对瓜氨酸化和天然波形蛋白的自身反应性T细胞可能成为监测或干预靶点。
局限性
- 研究限于北美原住民人群,结论外推至其他人群需谨慎。
- 原文未报告T细胞分析的具体样本量及统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The pathogenetic mechanisms by which HLA-DRB1 alleles are associated with anticitrullinated peptide antibody (ACPA)-positive rheumatoid arthritis (RA) are incompletely understood. RA high-risk HLA-DRB1 alleles are known to share a common motif, the 'shared susceptibility epitope (SE)'. Here, the electropositive P4 pocket of HLA-DRB1 accommodates self-peptide residues containing citrulline but not arginine. HLA-DRB1 His/Phe13β stratifies with ACPA-positive RA, while His13βSer polymorphisms stratify with ACPA-negative RA and RA protection. Indigenous North American (INA) populations have high risk of early-onset ACPA-positive RA, whereby HLA-DRB1*04:04 and HLA-DRB1*14:02 are implicated as risk factors for RA in INA. However, HLA-DRB1*14:02 has a His13βSer polymorphism. Therefore, we aimed to verify this association and determine its molecular mechanism. METHODS: HLA genotype was compared in 344 INA patients with RA and 352 controls. Structures of HLA-DRB1*1402-class II loaded with vimentin-64Arg59-71, vimentin-64Cit59-71 and fibrinogen β-74Cit69-81 were solved using X-ray crystallography. Vimentin-64Cit59-71-specific and vimentin59-71-specific CD4+ T cells were characterised by flow cytometry using peptide-histocompatibility leukocyte antigen (pHLA) tetramers. After sorting of antigen-specific T cells, TCRα and β-chains were analysed using multiplex, nested PCR and sequencing. RESULTS: ACPA+ RA in INA was independently associated with HLA-DRB1*14:02. Consequent to the His13βSer polymorphism and altered P4 pocket of HLA-DRB1*14:02, both citrulline and arginine were accommodated in opposite orientations. Oligoclonal autoreactive CD4+ effector T cells reactive with both citrulline and arginine forms of vimentin59-71 were observed in patients with HLA-DRB1*14:02+ RA and at-risk ACPA- first-degree relatives. HLA-DRB1*14:02-vimentin59-71-specific and HLA-DRB1*14:02-vimentin-64Cit59-71-specific CD4+ memory T cells were phenotypically distinct populations. CONCLUSION: HLA-DRB1*14:02 broadens the capacity for citrullinated and native self-peptide presentation and T cell expansion, increasing risk of ACPA+ RA.
引用
- Scally SW, Law SC, Ting YT, et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann Rheum Dis. 2017. PMID: 28801345. doi:10.1136/annrheumdis-2017-211300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。